C7A.092 – Malignant carcinoid tumor of the stomach

ICD-10-CM 2027 diagnosis code · Malignant neuroendocrine tumors (C7A)

Billable code

ICD-10-CM code C7A.092
Code
C7A.092 (claims format: C7A092)
Description
Malignant carcinoid tumor of the stomach
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
2. Neoplasms (C00-D49)
Block
C7A Malignant neuroendocrine tumors (C7A)
Parent codes
C7A › C7A.0 › C7A.09

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

C7A – Malignant neuroendocrine tumors

Excludes2 (not included here):
  • malignant pancreatic islet cell tumors (C25.4)
  • Merkel cell carcinoma (C4A.-)
Use additional code:
  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome (E34.00)
Code also:
  • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Index terms for C7A.092

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in C7A.09

Frequently asked questions

What is ICD-10 code C7A.092?

C7A.092 is the ICD-10-CM code for malignant carcinoid tumor of the stomach, in the block C7A (Malignant neuroendocrine tumors (C7A)).

Is C7A.092 a billable code?

Yes. C7A.092 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does C7A.092 belong to?

It belongs to category C7A – Malignant neuroendocrine tumors.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.